ZA856807B - A tumor therapeutic agent and a process for its preparation - Google Patents

A tumor therapeutic agent and a process for its preparation

Info

Publication number
ZA856807B
ZA856807B ZA856807A ZA856807A ZA856807B ZA 856807 B ZA856807 B ZA 856807B ZA 856807 A ZA856807 A ZA 856807A ZA 856807 A ZA856807 A ZA 856807A ZA 856807 B ZA856807 B ZA 856807B
Authority
ZA
South Africa
Prior art keywords
therapeutic agent
preparation
tumor therapeutic
monoclonal antibodies
antigens
Prior art date
Application number
ZA856807A
Other languages
English (en)
Inventor
Klaus Bosslet
Hans-Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA856807B publication Critical patent/ZA856807B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Window Of Vehicle (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA856807A 1984-09-06 1985-09-05 A tumor therapeutic agent and a process for its preparation ZA856807B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843432714 DE3432714A1 (de) 1984-09-06 1984-09-06 Tumortherapeutikum und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
ZA856807B true ZA856807B (en) 1986-04-30

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA856807A ZA856807B (en) 1984-09-06 1985-09-05 A tumor therapeutic agent and a process for its preparation

Country Status (13)

Country Link
EP (1) EP0173951B1 (fi)
JP (1) JPS6168427A (fi)
AT (1) ATE64531T1 (fi)
CA (1) CA1277600C (fi)
DE (2) DE3432714A1 (fi)
DK (1) DK172253B1 (fi)
ES (1) ES8704082A1 (fi)
FI (1) FI88360C (fi)
GR (1) GR852149B (fi)
IE (1) IE58638B1 (fi)
IL (1) IL76289A (fi)
PT (1) PT81093B (fi)
ZA (1) ZA856807B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
AT398900B (de) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vakzine für eine immuntherapie
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
US7037647B1 (en) 1995-02-24 2006-05-02 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (de) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Lyophilisat-Vakzine
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
EP3184539A3 (en) 2001-10-23 2017-09-13 PSMA Development Company L.L.C. Psma antibodies
CN1315536C (zh) * 2002-09-13 2007-05-16 李进 肿瘤抗原疫苗及其制备方法和疫苗组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (de) * 1976-09-25 1978-04-06 Bayer Ag Cancerostatisch wirksame praeparationen aus tumorzellen und ein verfahren zu ihrer herstellung
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (de) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg Arzneipraeparat zur behandlung von carcinomen und verfahren zu dessen herstellung
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (de) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene
DE3416774A1 (de) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg Monoklonale antikoerper, verfahren zu ihrer herstellung sowie ihre verwendung

Also Published As

Publication number Publication date
FI853389A0 (fi) 1985-09-04
ES546701A0 (es) 1987-03-16
FI853389L (fi) 1986-03-07
DK402485D0 (da) 1985-09-03
GR852149B (fi) 1986-01-03
DK172253B1 (da) 1998-02-09
IL76289A0 (en) 1986-01-31
PT81093B (pt) 1988-07-01
DE3583265D1 (de) 1991-07-25
ATE64531T1 (de) 1991-07-15
JPS6168427A (ja) 1986-04-08
DE3432714A1 (de) 1986-04-24
PT81093A (de) 1985-10-01
EP0173951B1 (de) 1991-06-19
ES8704082A1 (es) 1987-03-16
DK402485A (da) 1986-03-07
EP0173951A3 (en) 1988-06-08
FI88360B (fi) 1993-01-29
CA1277600C (en) 1990-12-11
IE852191L (en) 1986-03-06
EP0173951A2 (de) 1986-03-12
IE58638B1 (en) 1993-10-20
IL76289A (en) 1992-01-15
FI88360C (fi) 1993-05-10

Similar Documents

Publication Publication Date Title
IL90990A0 (en) Pharmaceutical and diagnostic compositions containing monoclonal antibodies reactive with cachectin and a cell for the production thereof
EP0161606A3 (en) Drug, and methods of preparing and using it for treatment of tumors
EP0260610A3 (en) Monoclonal antibodies against human tumour necrotic factor (tnf), and their use
HUT71193A (en) Tumor specific monoclonal antibody and cell line and pharmaceutical preparations containing them
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
ZA856807B (en) A tumor therapeutic agent and a process for its preparation
DE3173342D1 (en) Agent for tumor localization and therapy with labeled antibodies and antibody fragments
ZA897858B (en) Family of high affinity,modified antibodies for cancer treatment
CA2192079A1 (en) Human Monoclonal Antibodies Specific to Cell Cycle Independent Glioma Surface Antigen
EP0194851A3 (en) Human tumor therapy
ZA837857B (en) Platinum-diamine complexes,a process for the preparation thereof and a process for the preparation of a medical composition using such a complex for the treatment of cancer
EP0173663A3 (en) The use of a specific tumor associated antigen, sialosyllactotetraose, in diagnostic or therapeutic procedures related to cancer deseases
ZA772648B (en) Tumor antigen and process for the preparation thereof
DK169987D0 (da) Human tumor-associated antigen, ca-ou1
EP0268640A4 (en) VACCINE STIMULATING OR IMPROVING THE PRODUCTION OF ANTIBODIES AGAINST GM2.
HUT43495A (en) Process for production and compound for treating of cancer and beningn tumor
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
GR862238B (en) Monoclonal antibodies against glycoprotein associated with tumor, processes for their preparation and their use
EP0328578A4 (en) ANTIGEN IDENTIFIED BY MCA 16-88.
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
GB2048069B (en) Medicinal preparations for treating carcinomas
EP0207170A4 (en) METHOD FOR PRODUCING HUMAN CANCER-SPECIFIC MONOCLONAL ANTIBODIES.
EP0341318A4 (en) Novel platinum (ii) complex, process for preparing the same, and therapeutic agent for malignant tumor
ZA886752B (en) Tumor immunotherapy using anti-idiotypic antibodies
AR245225A1 (es) Composiciones para el tratamiento de cuero.